Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Net Income 2020–2025
Insight Molecular Diagnostics Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Insight Molecular Diagnostics Inc. net income for the quarter ending March 31, 2026 was -4.3 M, a 35.69% decrease year-over-year.
- Insight Molecular Diagnostics Inc. net income for the twelve months ending March 31, 2026 was -31.6 M, a 6.19% decrease year-over-year.
- Insight Molecular Diagnostics Inc. annual net income for 2025 was -50.2 M, a 17.21% decrease from 2024.
- Insight Molecular Diagnostics Inc. annual net income for 2024 was -60.7 M, a 118.36% increase from 2023.
- Insight Molecular Diagnostics Inc. annual net income for 2023 was -27.8 M, a 61.89% decrease from 2022.
- Insight Molecular Diagnostics Inc. annual net income for 2022 was -72.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Insight Molecular Diagnostics Inc. Net Income — FAQ
Insight Molecular Diagnostics Inc. (IMDX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Insight Molecular Diagnostics Inc.'s net income?
Insight Molecular Diagnostics Inc. (IMDX) reported net income of -$50M for fiscal 2025.
Where can I see IMDX's net income history?
The chart and table above show Insight Molecular Diagnostics Inc.'s net income by year and by quarter, including the growth rate.